Summary : OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα…
Work
-
-
CompaniesPfizer
Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
by adminby adminSummary : Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100%…
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsPfizerWest-Coast Pharmaceutical works Ltd
Pfizer Inc filed a Patent Infringement suit against West-Coast Pharmaceutical works Ltd.
by adminby adminSummary : Pfizer Inc. (plaintiff) filed a patent infringement suit against West-Coast Pharmaceutical works Ltd. (defendant) for inviting manufacturers to contract with…
-
Summary : A new study has found that artificial intelligence (AI) apps helped protect small and medium-sized businesses against many of the…
-
CompaniesCovid DrugsModernaPfizerRegulatoryU.S FDA
Moderna and Pfizer are Well-Positioned to Take mRNA into the Future
by adminby adminSummary : It’s an understatement to note that the bottom lines for Moderna and Pfizer have been fattened by the success of…
-
Covid DrugsRegulatoryU.S FDA
Ocugen Ends Week on Low as FDA Rejects Covaxin EUA for Kids
by adminby adminSummary : The U.S. Food and Drug Administration turned down Ocugen’s Emergency Use Authorization (EUA) request for Covaxin in children 2 to…
-
Global MarketMerger / Acquisition
SeQuent Scientific acquires Brazil-based animal drug firm for $5 million
by adminby adminSummary : PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Sade e Nutrio Animal Ltd for $5mn (Rs36.2cr),…
-
RegulatoryU.S FDA
J&J, Legend Introduce New CAR-T Therapy to Multiple Myeloma Market
by adminby adminSummary : Johnson & Johnson’s partner, Legend Biotech, has been awarded U.S. Food and Drug Administration approval for its chimeric antigen receptor…
-
GileadRegulatoryU.S FDA
FDA Rejects Gilead’s Long-Acting HIV Drug Over Vial Issues
by adminby adminSummary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…
-
AbbVieCompaniesMerger / Acquisition
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
by adminby adminSummary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…